Tokyo Tape
Sign in
← PHC Holdings

Annual report

6523.TEDINET S100OLA5
Period2021-04-01 → 2022-03-31
Filed2022-06-29
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 130
MetricValuePeriodScopeSource row
Revenue¥340.5bn2021-04-01 → 2022-03-31Cons.Revenue IFRS
Revenue¥306.1bn2020-04-01 → 2021-03-31Cons.Revenue IFRS
Revenue¥272.6bn2019-04-01 → 2020-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥186.5bn2018-04-01 → 2019-03-31dCons.Revenue IFRS (5-year summary)
Operating income¥8.2bn2021-04-01 → 2022-03-31Cons.Operating profit loss IFRS
Operating income¥17.6bn2020-04-01 → 2021-03-31Cons.Operating profit loss IFRS
Profit before tax¥3.0bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS
Profit before tax¥22.8bn2020-04-01 → 2021-03-31Cons.Profit loss before tax IFRS
Profit before tax¥5.6bn2019-04-01 → 2020-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥20.6bn2018-04-01 → 2019-03-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)−¥8.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥16.9bn2020-04-01 → 2021-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥5.3bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥15.5bn2018-04-01 → 2019-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income−¥8.3bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS
Net income¥16.8bn2020-04-01 → 2021-03-31Cons.Profit loss IFRS
Total assets¥591.3bnat 2022-03-31Cons.Assets IFRS
Total assets¥569.3bnat 2021-03-31Cons.Assets IFRS
Total assets¥529.8bnat 2020-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥325.2bnat 2019-03-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥455.3bnat 2022-03-31Cons.Liabilities IFRS
Total liabilities¥461.8bnat 2021-03-31Cons.Liabilities IFRS
Net assets / equity¥136.1bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥107.6bnat 2021-03-31Cons.Equity IFRS
Net assets / equity¥70.3bnat 2020-03-31dCons.Equity IFRS
Equity (owners)¥135.4bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥107.0bnat 2021-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥70.3bnat 2020-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥65.3bnat 2019-03-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥95.2bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥60.8bnat 2021-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥45.4bnat 2020-03-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥50.1bnat 2019-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥51.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥47.9bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥36.9bn2019-04-01 → 2020-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥33.8bn2018-04-01 → 2019-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥12.5bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥16.3bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥135.5bn2019-04-01 → 2020-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥7.4bn2018-04-01 → 2019-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥7.0bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥20.4bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥95.6bn2019-04-01 → 2020-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥19.9bn2018-04-01 → 2019-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥-70.782021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥149.072020-04-01 → 2021-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥46.612019-04-01 → 2020-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥135.842018-04-01 → 2019-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-70.782021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥143.932020-04-01 → 2021-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥45.222019-04-01 → 2020-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥130.452018-04-01 → 2019-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥1,092.33at 2022-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥921.04at 2021-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥619.38at 2020-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥579.44at 2019-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio22.9%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio18.8%at 2021-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio13.3%at 2020-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio20.1%at 2019-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE-7.0%2021-04-01 → 2022-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE19.1%2020-04-01 → 2021-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE7.8%2019-04-01 → 2020-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE26.0%2018-04-01 → 2019-03-31dCons.Rate of return on equity IFRS (5-year summary)
Employees9,374at 2022-03-31Cons.Number of employees
Employees9,753at 2021-03-31Cons.Number of employees
Employees9,615at 2020-03-31dCons.Number of employees
Employees5,368at 2019-03-31dCons.Number of employees
Revenue¥39.2bn2021-04-01 → 2022-03-31StandaloneOperating revenue1
Revenue¥8.8bn2020-04-01 → 2021-03-31StandaloneOperating revenue1
Revenue¥7.8bn2019-04-01 → 2020-03-31dStandaloneOperating revenue1 (5-year summary)
Revenue¥7.1bn2018-04-01 → 2019-03-31dStandaloneOperating revenue1 (5-year summary)
Revenue¥6.7bn2017-04-01 → 2018-03-31dStandaloneOperating revenue1 (5-year summary)
Operating income¥24.5bn2021-04-01 → 2022-03-31StandaloneOperating income
Operating income−¥2.1bn2020-04-01 → 2021-03-31StandaloneOperating income
Ordinary income¥21.0bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income−¥4.1bn2020-04-01 → 2021-03-31StandaloneOrdinary income
Ordinary income−¥9.5bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥606m2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥1.7bn2017-04-01 → 2018-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥18.7bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Profit before tax−¥4.2bn2020-04-01 → 2021-03-31StandaloneIncome before income taxes
Net income¥19.9bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income−¥132m2020-04-01 → 2021-03-31StandaloneProfit loss
Net income−¥10.5bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income−¥137m2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Net income¥757m2017-04-01 → 2018-03-31dStandaloneNet income loss (5-year summary)
Total assets¥467.3bnat 2022-03-31StandaloneAssets
Total assets¥432.7bnat 2021-03-31StandaloneAssets
Total assets¥408.9bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥250.3bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total assets¥275.0bnat 2018-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥370.5bnat 2022-03-31StandaloneLiabilities
Total liabilities¥382.1bnat 2021-03-31StandaloneLiabilities
Net assets / equity¥96.8bnat 2022-03-31StandaloneNet assets
Net assets / equity¥50.6bnat 2021-03-31StandaloneNet assets
Net assets / equity¥40.3bnat 2020-03-31dStandaloneNet assets
Net assets / equity¥50.2bnat 2019-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥53.0bnat 2018-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥50.6bnat 2022-03-31StandaloneCash and deposits
Cash and deposits¥25.1bnat 2021-03-31StandaloneCash and deposits
EPS (basic)¥166.622021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-1.172020-04-01 → 2021-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-92.712019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-1.212018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥6.662017-04-01 → 2018-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥161.082021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
Net assets per share¥763.79at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥428.12at 2021-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥355.31at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥445.36at 2019-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥466.02at 2018-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio20.3%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio11.5%at 2021-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio9.9%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio20.0%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio19.3%at 2018-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE27.6%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE1.4%2017-04-01 → 2018-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued124,144,242at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued114,831,084at 2021-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued111,973,941at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued111,871,099at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued111,871,099at 2018-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees175at 2022-03-31StandaloneNumber of employees
Employees181at 2021-03-31StandaloneNumber of employees
Employees186at 2020-03-31dStandaloneNumber of employees
Employees175at 2019-03-31dStandaloneNumber of employees
Employees156at 2018-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 35
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2022-03-31654 pure
Reconciling Itemsreconcilingrevenue2021-04-01 → 2022-03-31¥2.6bn
Reconciling Itemsreconcilingrevenue external2021-04-01 → 2022-03-31¥2.6bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2022-03-31−¥18.0bn
Diabetes Managementreportable segmentemployeesat 2022-03-312620 pure
Diabetes Managementreportable segmentrevenue2021-04-01 → 2022-03-31¥109.4bn
Diabetes Managementreportable segmentrevenue external2021-04-01 → 2022-03-31¥109.4bn
Diabetes Managementreportable segmentsegment profit2021-04-01 → 2022-03-31¥23.3bn
Diagnostics And Life Sciencesreportable segmentemployeesat 2022-03-311958 pure
Diagnostics And Life Sciencesreportable segmentrevenue2021-04-01 → 2022-03-31¥92.2bn
Diagnostics And Life Sciencesreportable segmentrevenue external2021-04-01 → 2022-03-31¥92.2bn
Diagnostics And Life Sciencesreportable segmentsegment profit2021-04-01 → 2022-03-31−¥14.1bn
Healthcare Solutionsreportable segmentemployeesat 2022-03-314142 pure
Healthcare Solutionsreportable segmentrevenue2021-04-01 → 2022-03-31¥136.3bn
Healthcare Solutionsreportable segmentrevenue external2021-04-01 → 2022-03-31¥136.3bn
Healthcare Solutionsreportable segmentsegment profit2021-04-01 → 2022-03-31¥17.0bn
—segment totalrevenue2021-04-01 → 2022-03-31¥337.9bn
—segment totalrevenue external2021-04-01 → 2022-03-31¥337.9bn
—segment totalsegment profit2021-04-01 → 2022-03-31¥26.1bn
Reconciling Itemsreconcilingrevenue2020-04-01 → 2021-03-31¥1.9bn
Reconciling Itemsreconcilingrevenue external2020-04-01 → 2021-03-31¥1.9bn
Reconciling Itemsreconcilingsegment profit2020-04-01 → 2021-03-31−¥11.4bn
Diabetes Managementreportable segmentrevenue2020-04-01 → 2021-03-31¥108.1bn
Diabetes Managementreportable segmentrevenue external2020-04-01 → 2021-03-31¥108.1bn
Diabetes Managementreportable segmentsegment profit2020-04-01 → 2021-03-31¥23.9bn
Diagnostics And Life Sciencesreportable segmentrevenue2020-04-01 → 2021-03-31¥79.9bn
Diagnostics And Life Sciencesreportable segmentrevenue external2020-04-01 → 2021-03-31¥79.9bn
Diagnostics And Life Sciencesreportable segmentsegment profit2020-04-01 → 2021-03-31¥508m
Healthcare Solutionsreportable segmentrevenue2020-04-01 → 2021-03-31¥116.1bn
Healthcare Solutionsreportable segmentrevenue external2020-04-01 → 2021-03-31¥116.1bn
Healthcare Solutionsreportable segmentsegment profit2020-04-01 → 2021-03-31¥4.5bn
—segment totalrevenue2020-04-01 → 2021-03-31¥304.1bn
—segment totalrevenue external2020-04-01 → 2021-03-31¥304.1bn
—segment totalsegment profit2020-04-01 → 2021-03-31¥29.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2022-03-31175 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,993
ItemContextValueUnit
Total shareholder returnPrior2YearInstant_NonConsolidatedMember－
Total shareholder returnPrior1YearInstant_NonConsolidatedMember－
Total shareholder returnCurrentYearInstant_NonConsolidatedMember－
Total return on share price indexPrior4YearInstant_NonConsolidatedMember－
Total return on share price indexPrior3YearInstant_NonConsolidatedMember－
Total return on share price indexPrior2YearInstant_NonConsolidatedMember－
Total return on share price indexPrior1YearInstant_NonConsolidatedMember－
Total return on share price indexCurrentYearInstant_NonConsolidatedMember－
Number of employeesCurrentYearInstant_jpcrp030000-asr_E36976-000DiabetesManagementReportableSegmentMember2620
Average number of temporary workersCurrentYearInstant_jpcrp030000-asr_E36976-000DiabetesManagementReportableSegmentMember25
Number of employeesCurrentYearInstant_jpcrp030000-asr_E36976-000HealthcareSolutionsReportableSegmentMember4142
Average number of temporary workersCurrentYearInstant_jpcrp030000-asr_E36976-000HealthcareSolutionsReportableSegmentMember1872
Number of employeesCurrentYearInstant_jpcrp030000-asr_E36976-000DiagnosticsAndLifeSciencesReportableSegmentMember1958
Average number of temporary workersCurrentYearInstant_jpcrp030000-asr_E36976-000DiagnosticsAndLifeSciencesReportableSegmentMember521
Number of employeesCurrentYearInstant_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember654
Average number of temporary workersCurrentYearInstant_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember43
Number of employeesCurrentYearInstant9374
Average number of temporary workersCurrentYearInstant2461
Number of employeesCurrentYearInstant_NonConsolidatedMember175
Average number of temporary workersCurrentYearInstant_NonConsolidatedMember15
Average age years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember47.9
Average length of service years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember17.4
Average annual salary information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember9032968JPY
Number of employeesCurrentYearInstant_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember175
Average number of temporary workersCurrentYearInstant_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember15
Number of employeesCurrentYearInstant_NonConsolidatedMember175
Average number of temporary workersCurrentYearInstant_NonConsolidatedMember15
Research and development expenses research and development activitiesCurrentYearDuration10262000000JPY
Research and development expenses research and development activitiesCurrentYearDuration_jpcrp030000-asr_E36976-000DiabetesManagementReportableSegmentMember2802000000JPY
Research and development expenses research and development activitiesCurrentYearDuration_jpcrp030000-asr_E36976-000HealthcareSolutionsReportableSegmentMember2320000000JPY
Research and development expenses research and development activitiesCurrentYearDuration_jpcrp030000-asr_E36976-000DiagnosticsAndLifeSciencesReportableSegmentMember3709000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration11736000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration_jpcrp030000-asr_E36976-000DiabetesManagementReportableSegmentMember1528000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration_jpcrp030000-asr_E36976-000HealthcareSolutionsReportableSegmentMember7239000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration_jpcrp030000-asr_E36976-000DiagnosticsAndLifeSciencesReportableSegmentMember2681000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember124144242
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember124284857
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant124144242
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant124284857
Number of shares constituting one unitCurrentYearInstant_OrdinaryShareMember100
Number of shareholders national and local governmentsCurrentYearInstant_OrdinaryShareMember－
Number of shareholders financial institutionsCurrentYearInstant_OrdinaryShareMember15
Number of shareholders financial service providersCurrentYearInstant_OrdinaryShareMember39
Number of shareholders other corporationsCurrentYearInstant_OrdinaryShareMember436
Number of shareholders foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember63
Number of shareholders foreign individual investorsCurrentYearInstant_OrdinaryShareMember71
Number of shareholders individuals and othersCurrentYearInstant_OrdinaryShareMember17940
Number of shareholders totalCurrentYearInstant_OrdinaryShareMember18564
Number of shares held number of units national and local governmentsCurrentYearInstant_OrdinaryShareMember－
Number of shares held number of units financial institutionsCurrentYearInstant_OrdinaryShareMember47755

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2021-03-31pass
balance sheet identityconsolidated 2022-03-31pass
balance sheet identitynon_consolidated 2021-03-31pass
balance sheet identitynon_consolidated 2022-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2020-04-01/2021-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2020-04-01/2021-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2020-04-01/2021-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsconsolidated 2021-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2021-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass